Optical disc drive

Hitachi LG Data Storage Announces New CEO and CFO: Hayata Makoto and Kang Jae Wook

Retrieved on: 
Tuesday, February 6, 2024
Multimedia, HLDS, Growth, CFO, Drive, Solid-state drive, Electronics, Optical disc drive, Waseda University, Kyungpook National University, Political economy, LG Electronics, Odds, Thermoplastic

Hitachi LG Data Storage (HLDS), a global joint venture between Hitachi and LG Electronics, has dominated the data storage industry for over 23 years.

Key Points: 
  • Hitachi LG Data Storage (HLDS), a global joint venture between Hitachi and LG Electronics, has dominated the data storage industry for over 23 years.
  • CEO Hayata graduated from Waseda University's Department of Political Economy in 1985, and he embarked on his career at Hitachi.
  • 2024.01 – Present CEO of Hitachi LG Data Storage, Inc
    2023.04 – 2024.01 CFO of Hitachi LG Data Storage, Inc
    2020.04 – 2023.03 Hitachi, Ltd. Head of Industries Audit Office, Connective Industries Business General Headquarters
    2014.04 – 2018.03 Hitachi, Ltd. Director of Financial Process Solutions.
  • Finance General Headquarters
    2024.01 – Present CFO of Hitachi LG Data Storage, Inc
    2003.12 – 2016.01 CFO of LG Electronics (Chile, Colombia, and Brazil),
    View original content to download multimedia: https://www.prnewswire.com/news-releases/hitachi-lg-data-storage-announc...

Cboe Global Markets Reports July 2021 Trading Volume

Retrieved on: 
Wednesday, August 4, 2021
CFTC, Investment, Maintenance, HYG, VIX, Person, Characteristic, SPX, Optical disc drive, Limited liability company, Suite, No, S&P 500, IHS Markit, Financial services, Option, View, Communication, Sale, S&P Global Ratings, Cboe Global Markets, Markit, Multimedia, Contract, Risk, Failure, IBoxx, BlackRock, IShares, Standard, Options Clearing Corporation, CFE, Financial adviser, Life insurance, Security (finance), Insurance

Cboe, Cboe Global Markets, Cboe Volatility Index, CFE, and VIX are registered trademarks and Cboe Futures ExchangeSM is a service markof Cboe Exchange, Inc. or its affiliates.

Key Points: 
  • Cboe, Cboe Global Markets, Cboe Volatility Index, CFE, and VIX are registered trademarks and Cboe Futures ExchangeSM is a service markof Cboe Exchange, Inc. or its affiliates.
  • Cboe Global Markets, Inc. and its affiliates do not recommend or make any representation as to possible benefits from any securities, futures or investments, or third-party products or services.
  • Cboe Global Markets, Inc. is not affiliated with S&P, Russell, iShares or IHS Markit.
  • Cboe Global Markets, Inc. disclaims any duty to update the information herein.

Cboe Global Markets Reports July 2021 Trading Volume

Retrieved on: 
Wednesday, August 4, 2021
CFTC, Investment, Maintenance, HYG, VIX, Person, Characteristic, SPX, Optical disc drive, Limited liability company, Suite, No, S&P 500, IHS Markit, Financial services, Option, Communication, Sale, S&P Global Ratings, Cboe Global Markets, Markit, Contract, Risk, Failure, IBoxx, BlackRock, IShares, Standard, Options Clearing Corporation, CFE, Financial adviser, Life insurance, Security (finance), Insurance

Cboe, Cboe Global Markets, Cboe Volatility Index, CFE, and VIX are registered trademarks and Cboe Futures ExchangeSM is a service markof Cboe Exchange, Inc. or its affiliates.

Key Points: 
  • Cboe, Cboe Global Markets, Cboe Volatility Index, CFE, and VIX are registered trademarks and Cboe Futures ExchangeSM is a service markof Cboe Exchange, Inc. or its affiliates.
  • Cboe Global Markets, Inc. and its affiliates do not recommend or make any representation as to possible benefits from any securities, futures or investments, or third-party products or services.
  • Cboe Global Markets, Inc. is not affiliated with S&P, Russell, iShares or IHS Markit.
  • Cboe Global Markets, Inc. disclaims any duty to update the information herein.

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis

Retrieved on: 
Wednesday, August 4, 2021
Health sciences, Health, Food and Drug Administration, Life sciences, Pharmaceuticals policy, Drug discovery, Biotechnology law, Orphan drug, Orphan Drug Act, Clinical trial, Food and Drug Administration Safety and Innovation Act, Breakthrough therapy

The FDA evaluated the research data licensed from KU in the ODD application that ultimately served as the foundation to allow the FDA to grant the designation.

Key Points: 
  • The FDA evaluated the research data licensed from KU in the ODD application that ultimately served as the foundation to allow the FDA to grant the designation.
  • The Orphan Drug Act grants special status to a drug or biological product to treat a rare disease or condition upon request of a sponsor.
  • The FDA grants orphan status to products that treat rare diseases, providing incentives to sponsors developing drugs or biologics.
  • PharmaTher is currently initiating an FDA approved phase 2 clinical study with ketamine to treat Parkinsons disease and is developing a novel microneedle patch for the intradermal delivery of psychedelics.

Odd Burger Completes Construction of London, ON Location, Two More to Open Soon

Retrieved on: 
Tuesday, August 3, 2021
Fast-food restaurants, Restaurants, Fast food, Burger King, Burger King franchises, Competitive Foods Australia

Odd Burger South London (645 Commissioners Road East) brings the chain's total to four locations, with two additional restaurants set to open soon.

Key Points: 
  • Odd Burger South London (645 Commissioners Road East) brings the chain's total to four locations, with two additional restaurants set to open soon.
  • Odd Burger also announced progress at its Waterloo, ON (75 King Street South) and Hamilton, ON (920 Upper Wentworth Street) locations.
  • All new stores incorporate the new Odd Burger brand and design in interior decor and signage.
  • Odd Burger plans to open 20 locations by this time next year, including a flagship New York City restaurant in Manhattan.

Epygenix Therapeutics Receives U.S. FDA Orphan Drug Designation for EPX-200 in Lennox-Gastaut Syndrome

Retrieved on: 
Monday, August 2, 2021
Health, Life sciences, Lennox–Gastaut syndrome, LGS, EPX, Epilepsy, Orphan drug, Lennox

PARAMUS, N.J., Aug. 2, 2021 /PRNewswire/ --Epygenix Therapeutics, Inc., a clinical stage biopharmaceutical company focused on rare and intractable genetic epilepsy, today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to EPX-200 for the treatment of Lennox-Gastaut Syndrome (LGS).

Key Points: 
  • PARAMUS, N.J., Aug. 2, 2021 /PRNewswire/ --Epygenix Therapeutics, Inc., a clinical stage biopharmaceutical company focused on rare and intractable genetic epilepsy, today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to EPX-200 for the treatment of Lennox-Gastaut Syndrome (LGS).
  • "Granting Orphan Drug Designation for LGS to EPX-200 is one of the company's significant development milestones, because the Company is expanding targeted indications to multiple refractory epilepsies, including LGS.
  • The FDA's ODD grant to EPX-200 for LGS recognizes the significance of EPX-200 as a drug candidate for these patients.
  • EPX-200 also has been reported to have anti-seizure effects based on the result from small number of patients.

Industry leader HLDS aims Amazon US with 'Portable DVD for Multi-OS'

Retrieved on: 
Monday, January 11, 2021
Computing, Technology, Operating systems, Hitachi, Hitachi-LG Data Storage, LG Corporation, Cloud clients, HLDS, Smartphones, Audio storage, Android, Optical disc drive

SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Hitachi-LG Data Storage (HLDS), the reliable market leader in the ODD industry, launched 'Portable DVD for Multi-OS' from January 1st through Amazon US.

Key Points: 
  • SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Hitachi-LG Data Storage (HLDS), the reliable market leader in the ODD industry, launched 'Portable DVD for Multi-OS' from January 1st through Amazon US.
  • 'The portable DVD for Multi-OS' is the world's first Android, Windows, and Mac OS compatible DVDRW, allowing the users to use DVD with not only PC but also Android devices.
  • HLDS has increased its market dominance in Optical Disc Drive market and maintained its global No.1 position for over 20 years.
  • Now HLDS expands its business area from ODD to wireless chargers and sensors product-wise and from enterprise to individual customers target-wise.

Vinpower Digital announces the release of the exclusive Pioneer BDR-212V drive in cooperation with Pioneer Corporation

Retrieved on: 
Tuesday, December 8, 2020
Storage media, Information and communications technology, Audio storage, Data storage, Consumer electronics, Home video, High-definition television, DVD, Pioneer Corporation, Optical disc drive, Blu-ray, Optical disc

LOS ANGELES, Dec. 8, 2020 /PRNewswire-PRWeb/ -- Vinpower Digital ("Vinpower"), a recognized global manufacturer and distributor of digital duplication equipment and accessories, is announcing the release of the new exclusive BDR-212V 16x internal BD/DVD/CD Half Height Optical Disc Drive (ODD), in collaboration with Pioneer Corporation ("Pioneer").

Key Points: 
  • LOS ANGELES, Dec. 8, 2020 /PRNewswire-PRWeb/ -- Vinpower Digital ("Vinpower"), a recognized global manufacturer and distributor of digital duplication equipment and accessories, is announcing the release of the new exclusive BDR-212V 16x internal BD/DVD/CD Half Height Optical Disc Drive (ODD), in collaboration with Pioneer Corporation ("Pioneer").
  • To overcome this lack of capabilities with DVD5 media, Vinpower joined forces with Pioneer to create the Pioneer BDR-212V drive.
  • We are proud to offer the Pioneer drive for the global duplication market," a representative of Pioneer Corporation stated.
  • "Even though it's a Blu-ray drive, the exclusive Pioneer BDR-212V drive, developed in cooperation between Vinpower and Pioneer, improves the DVD burning capabilities beyond those of competing DVD drives, yet remains competitively priced."

Sony Launches Generation 3 PetaSite Optical Disc Archive Library with 66 Percent Greater Capacity and 50 Percent Improvement in Archive Performance Versus Previous Generation

Retrieved on: 
Wednesday, June 3, 2020
Electronics, Data storage, Storage media, Audio storage, Optical disc authoring, Optical Disc Archive, Optical disc drive, Sony, Optical disc

PARAMUS, N.J., June 3, 2020 /PRNewswire/ -- Sony Electronics Inc. announces the launch of Generation 3 ("Gen3") PetaSite Optical Disc Archive technology, which is now shipping.

Key Points: 
  • PARAMUS, N.J., June 3, 2020 /PRNewswire/ -- Sony Electronics Inc. announces the launch of Generation 3 ("Gen3") PetaSite Optical Disc Archive technology, which is now shipping.
  • The high-capacity archival storage solution scales from 165 TB*1 to 2.9 PB*1 of immutable optical storage in a standard 42U Rack.
  • In keeping with Sony's commitment to its customers and focus on long-term archive solutions, The Gen3 enterprise class eight-channel, dual-sided optical drive is write compatible to Generation 2 and backward read compatible to all Optical Disc Archive cartridges.
  • "Sony's latest generation of optical drive technology addresses many issues with long-term storage, particularly with respect to its total cost of ownership," said Theresa Alesso, Pro Division president, Sony Electronics.